Results 101 to 110 of about 29,066 (192)
Antithrombotic Therapy Use in Children With Pulmonary Hypertension
ABSTRACT The role of antithrombotic therapy in pulmonary hypertension (PH) remains uncertain, with conflicting adult data and limited pediatric evidence. This study aimed to describe real‐world antithrombotic use in pediatric PH utilizing Pediatric Pulmonary Hypertension Network (PPHNet) registry data and a survey of PPHNet centers. We analyzed data of
Meredith J. O'Neil +23 more
wiley +1 more source
Pulmonary veno-occlusive disease has a significantly worse prognosis than idiopathic pulmonary arterial hypertension. According to a case series from France, the median survival time from diagnosis to death or lung transplantation was only 1 year, and in
Christian Hesse +3 more
doaj +1 more source
ABSTRACT Pulmonary arterial hypertension (PAH) is a chronic and progressive disease with substantial physiological and psychosocial burden. Effective patient education is essential for self‐management and improved outcomes, yet access to reliable information remains limited by brief clinic visits and variable‐quality external resources.
Denise G. Sese +5 more
wiley +1 more source
Abstract Objective To present a practical, evidence‐based framework for the management of headache disorders in pediatric patients with prior stroke or underlying cerebral vascular lesions, with particular attention to safety and efficacy of pharmacologic and non‐pharmacologic therapies.
Allison C. Hyland +7 more
wiley +1 more source
Spontaneous Hepatobiliary Disease in a Breeding Colony of Aotus spp.
ABSTRACT Background Owl monkeys are nonhuman primate species in the genus Aotus. The Michale E. Keeling Center for Comparative Medicine and Research maintains an Owl Monkey Breeding and Research Resource composed of four species of owl monkeys: Aotus nancymai, A. vociferans, A. azarae, and A. griseimembra.
M. E. Hensel +4 more
wiley +1 more source
Diagnostic and management dilemmas in pulmonary hypertension
Introduction Although current international guidelines provide comprehensive evidence-based guidance for the management of pulmonary hypertension, clinicians are still regularly faced with uncertainty regarding correct diagnosis and optimal treatment ...
Robin Condliffe +14 more
doaj +1 more source
ЛЕГОЧНАЯ АРТЕРИАЛЬНАЯ ГИПЕРТЕНЗИЯ КАК ПРОЯВЛЕНИЕ ПАРАНЕОПЛАСТИЧЕСКОГО СИНДРОМА ПРИ ГИПЕРНЕФР МЕ
We give a case report of idiopathic pulmonary arterial hypertension (PAH) in a male patient with cancer of kidney. The hypothesis of pathogenetic link between these diseases was made.
А. В. Ягода +4 more
doaj
[Treatment of idiopathic pulmonary arterial hypertension].
In the past 5-10 years, drug treatment of idiopathic pulmonary arterial hypertension has evolved considerably. Experience and results from use of such updated treatment in Norway has not been reported.32 patients newly diagnosed with idiopathic pulmonary arterial hypertension, were consecutively assessed with respect to hemodynamics and physical ...
Arne K, Andreassen +3 more
openaire +1 more source
Is It Still “Idiopathic”? Features of Autoimmunity in Idiopathic Pulmonary Arterial Hypertension
Tracy M. Frech, Eric D. Austin
openaire +2 more sources

